Enma Verónica Paez Espinosa

Dr. Enma Verónica Paez Espinosa

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
GSGIOVANNA REVILLA SENRA
GIOVANNA REVILLA SENRA
NQNuseibah AL Qtaish
Nuseibah AL Qtaish
PCPablo Caruana
Pablo Caruana
MSMyriam Sainz-Ramos
Myriam Sainz-Ramos
TLTania Lopez-Mendez
Tania Lopez-Mendez
EMEugenia Mato
Eugenia Mato
Background: Lenvatinib, a tyrosine kinase inhibitor (TKI) approved for the treatment of progressive and radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), is associated with significant adverse effects that can be partially mitigated through the development of novel drug formulations. The utilization of nanoparticles presents a viable option, as it allows for targeted drug delivery, reducing certain side effects and enhancing the overall quality of life for patients. This study aimed to produce and assess, both in vitro and in vivo, the cytotoxicity, biodistribution, and therapeutic efficacy of lenvatinib-loaded PLGA nanoparticles (NPs), both with and without decoration using antibody conjugation (cetuximab), as a novel therapeutic approach for managing aggressive thyroid tumors. Methods: Poly(lactic-co-glycolic acid) nanoparticles (NPs), decorated with or without anti-EGFR, were employed as a lenvatinib delivery system. These NPs were characterized for size distribution, surface morphology, surface charge, and drug encapsulation efficiency. Cytotoxicity was evaluated through MTT assays using two cellular models, one representing normal thyroid cells (Nthy-ori 3-1) and the other representing anaplastic thyroid cells (CAL-62). Additionally, an in vivo xenograft mouse model was established to investigate biodistribution and therapeutic efficacy following intragastric administration. Results: The NPs demonstrated success in terms of particle size, polydispersity index (PDI), zeta potential, morphology, encapsulation efficiency, and cetuximab distribution across the surface. In vitro analysis revealed cytotoxicity in both cellular models with both formulations, but only the decorated NPs achieved an ID50 value in CAL-62 cells. Biodistribution analysis following intragastric administration in xenografted thyroid mice demonstrated good stability in terms of intestinal barrier function and tumor accumulation. Both formulations were generally well tolerated without inducing pathological effects in the examined organs. Importantly, both formulations increased tumor necrosis; however, decorated NPs exhibited enhanced parameters related to apoptotic/karyolytic forms, mitotic index, and vascularization compared with NPs without decoration. Conclusions: These proof-of-concept findings suggest a promising strategy for administering TKIs in a more targeted and effective manner.

Verified
Journal Article
Open access
PDF file
EEEnma Verónica Paez Espinosa
Enma Verónica Paez Espinosa
EMEugenia Mato
Eugenia Mato
DGDelia María Sosa Guzmán
Delia María Sosa Guzmán
FKFadi Khasawneh
Fadi Khasawneh
Cardiovascular disease (CVD) is the primary cause of death and disability worldwide. Although age-standardized CVD mortality rates decreased globally by 14.5% between 2006 and 2016, the burden of CVD remains disproportionately higher in low- and middle-income countries compared to high-income countries. Even though proven, effective approaches based on multiple-drug intake aimed at the prevention and treatment of CVD are currently available, poor adherence, early discontinuation of treatment, and suboptimal daily execution of the prescribed therapeutic regimes give rise to shortfalls in drug exposure, leading to high variability in the responses to the prescribed medications. Wald and Law, in their landmark paper published in BMJ 2003, hypothesized that the use of a fixed-dose combination of statins, β-blockers, angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and aspirin (classic Polypill composition) may increase adherence and decrease CVD by up to 80% when prescribed as primary prevention or in substitution of traditional protocols. Since then, many clinical trials have tested this hypothesis, with comparable results. This review aims to describe the available clinical trials performed to assess the impact of fixed-dose combinations on adherence, cost-effectiveness, and the risk factors critical to the onset of CVD.

3 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DGDelia María Sosa Guzmán
Delia María Sosa Guzmán
MCMartín Israel Cáceres-Ruiz
Martín Israel Cáceres-Ruiz
NDNicole Dávila-Jumbo
Nicole Dávila-Jumbo
LBLuis René Buitrón-Andrade
Luis René Buitrón-Andrade
Vinicio Franciso Robalino FloresVinicio Franciso Robalino Flores
Vinicio Franciso Robalino Flores
EEEnma Verónica Paez Espinosa
Enma Verónica Paez Espinosa
Leishmaniasis is a parasitic disease spread through bites from female sandflies of the genus Lutzomyia. Ecuador has three natural regions, characterized by their drastic changes in temperature and altitude: the Andes, which extend over 3000 meters above sea level; the Coast; and the Amazonia, which reach up to 1000 meters in elevation. Most reported cases of Leishmaniasis in Ecuador are associated with humid climates, rural areas on the coast, the Amazonia, and the Andean valleys. However, our study revealed an unexpected trend-areas of the Andes traditionally characterized by a cold climate reported positive cases of Leishmaniasis. To address this issue, we performed an ecological exploratory study based on official information about morbidity and mortality due to Leishmaniasis during the last ten years in the province of Chimborazo, located in the heart of the Andes. We obtained the data from records stored on the Ecuadorian Health Care Registration Platform and conducted statistical analyses using SPSS software. We found that between 2013 and 2022, the area reported 40 confirmed cases of Leishmaniasis, with 97.5% being cutaneous and 2.5% mucocutaneous, predominantly affecting children and males. These unexpected findings underscore the importance of understanding and managing the spread of the disease due to climate change.

Verified
Journal Article
Open access
PDF file
EEEnma Verónica Paez Espinosa
Enma Verónica Paez Espinosa
DGDelia María Sosa Guzmán
Delia María Sosa Guzmán
LBLuis René Buitrón-Andrade
Luis René Buitrón-Andrade
NDNicole Dávila-Jumbo
Nicole Dávila-Jumbo
MCMartín Israel Cáceres-Ruiz
Martín Israel Cáceres-Ruiz
EMEugenia Mato
Eugenia Mato
Leishmaniasis is a parasitic disease transmitted by female sandflies of the genus Lutzomyia. Ecuador is divided into three distinct natural regions: the Andes, the Coast, and Amazonia, each characterized by significant variations in altitude and climate. While most reported cases of leishmaniasis are associated with humid, low-altitude rural areas, our study uncovered an unexpected trend: confirmed cases occurring in traditionally cold Andean regions. To investigate this issue, we conducted a cross-sectional ecological study using official morbidity and mortality records from the Ecuadorian Health Care Registration Platform, focusing on the cantons of Alausí and Chunchi in Chimborazo Province from 2013 to 2022. Chimborazo Province, in the Andes, is characterized by higher altitudes (2740 m above sea level) and a cold climate (averaging 13 °C throughout the year). Among a population of 44,089 residents in Alausí, we reported a total of 40 confirmed cases, with 97.5% classified as cutaneous and 2.5% as mucocutaneous, predominantly affecting children and males. No mortality cases were recorded during the study period. To further explore environmental influences, we examined the Alausí region, where climate change has led to rising average temperatures, deforestation, and changes in humidity levels. Leishmaniasis cases in Alausí showed seasonal peaks, particularly in 2018 and 2019, correlating with warmer and more humid conditions. Environmental factors such as temperature and humidity were strongly associated with the prevalence of the disease, suggesting that climate change may be increasing transmission risks. These findings point to the value of incorporating environmental monitoring into public health strategies for vector-borne diseases that affect vulnerable populations in the Andes.